ArticleEFSA journal. European Food Safety Authority2026
Avian influenza overview March-May 2026.
Article in EFSA journal. European Food Safety Authority, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Avian influenza overview June-August 2026.EFSA journal. European Food Safety Authority · 2026Article
- Avian influenza overview March-May 2026.EFSA journal. European Food Safety Authority · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Between 28 February and 4 June 2026, 949 highly pathogenic avian influenza (HPAI) A(H5) virus detections were reported in domestic (186) and wild (763) birds in 30 countries in Europe. The downward trend in the number of detections observed at the end of the previous reporting period continued and is expected to persist throughout the summer. While the number of HPAI A(H5N1) outbreaks in domestic birds remained at a low level, except in a few countries, A(H9N2) virus of clade G5.5 was detected in poultry in Europe for the first time. Following the intense circulation of HPAI viruses in waterfowl in recent months, sporadic detections were reported in mammals, particularly in wild carnivores, including the detection of A(H5N5) virus in a polar bear and a walrus in Norway. Outside Europe, the focus of HPAI virus detections shifted from North to South America, where a large number of outbreaks and mortality events in swans were reported. Between 28 February and 4 June 2026, 19 cases of avian influenza virus infection were publicly reported in humans (including three fatal cases) in six countries and territories: Bangladesh (two cases with A(H5N1), one fatal), Cambodia (three cases with A(H5N1), one fatal), India (one case with A(H5N1)), Italy (one imported case with A(H9N2)), China (10 A(H9N2) cases and one fatal A(H5N6) case), and Taiwan (one A(H7N7) case). Most human cases reported exposure to poultry or a poultry environment prior to detection or onset of illness. Human infections with avian influenza viruses remain rare and no sustained human-to-human transmission has been documented. The risk posed by avian influenza A(H5N1) clade 2.3.4.4b viruses currently circulating in Europe remains low for the general public in the European Union/European Economic Area (EU/EEA) and low-to-moderate for those occupationally or otherwise exposed to infected animals or contaminated environments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.